Johansson P, Jansson A, Ruetschi U, Rymo L
J Virol. 2008; 83(3):1393-401.
PMID: 19019967
PMC: 2620919.
DOI: 10.1128/JVI.01637-08.
Tierney R, Nagra J, Hutchings I, Shannon-Lowe C, Altmann M, Hammerschmidt W
J Virol. 2007; 81(18):10092-100.
PMID: 17626071
PMC: 2045388.
DOI: 10.1128/JVI.00358-07.
Jansson A, Johansson P, Yang W, Palmqvist L, Sjoblom-Hallen A, Rymo L
Virus Genes. 2007; 35(2):203-14.
PMID: 17546492
DOI: 10.1007/s11262-007-0116-x.
Borestrom C, Zetterberg H, Liff K, Rymo L
J Virol. 2002; 77(2):821-9.
PMID: 12502798
PMC: 140792.
DOI: 10.1128/jvi.77.2.821-829.2003.
Yoo L, Woloszynek J, Templeton S, Speck S
J Virol. 2002; 76(22):11763-9.
PMID: 12388739
PMC: 136791.
DOI: 10.1128/jvi.76.22.11763-11769.2002.
Epstein-Barr virus nuclear antigen 5 inhibits pre-mRNA cleavage and polyadenylation.
Dufva M, Flodin J, Nerstedt A, Ruetschi U, Rymo L
Nucleic Acids Res. 2002; 30(10):2131-43.
PMID: 12000833
PMC: 115292.
DOI: 10.1093/nar/30.10.2131.
Promoter-proximal regulatory elements involved in oriP-EBNA1-independent and -dependent activation of the Epstein-Barr virus C promoter in B-lymphoid cell lines.
Nilsson T, Zetterberg H, Wang Y, Rymo L
J Virol. 2001; 75(13):5796-811.
PMID: 11390581
PMC: 114295.
DOI: 10.1128/JVI.75.13.5796-5811.2001.
The Epstein-Barr virus promoter initiating B-cell transformation is activated by RFX proteins and the B-cell-specific activator protein BSAP/Pax5.
Tierney R, Kirby H, Nagra J, Rickinson A, Bell A
J Virol. 2000; 74(22):10458-67.
PMID: 11044090
PMC: 110920.
DOI: 10.1128/jvi.74.22.10458-10467.2000.
Characterization of gammaherpesvirus 68 gene 50 transcription.
Liu S, Pavlova I, Virgin 4th H, Speck S
J Virol. 2000; 74(4):2029-37.
PMID: 10644377
PMC: 111682.
DOI: 10.1128/jvi.74.4.2029-2037.2000.
Differential methylation of Epstein-Barr virus latency promoters facilitates viral persistence in healthy seropositive individuals.
Paulson E, Speck S
J Virol. 1999; 73(12):9959-68.
PMID: 10559309
PMC: 113046.
DOI: 10.1128/JVI.73.12.9959-9968.1999.
Silencing of the Epstein-Barr virus latent membrane protein 1 gene by the Max-Mad1-mSin3A modulator of chromatin structure.
Sjoblom-Hallen A, Yang W, Jansson A, Rymo L
J Virol. 1999; 73(4):2983-93.
PMID: 10074148
PMC: 104058.
DOI: 10.1128/JVI.73.4.2983-2993.1999.
An ATF/CRE element mediates both EBNA2-dependent and EBNA2-independent activation of the Epstein-Barr virus LMP1 gene promoter.
Sjoblom A, Yang W, Palmqvist L, Jansson A, Rymo L
J Virol. 1998; 72(2):1365-76.
PMID: 9445037
PMC: 124615.
DOI: 10.1128/JVI.72.2.1365-1376.1998.
B-cell lines immortalized with an Epstein-Barr virus mutant lacking the Cp EBNA2 enhancer are biased toward utilization of the oriP-proximal EBNA gene promoter Wp1.
Yoo L, Mooney M, Puglielli M, Speck S
J Virol. 1997; 71(12):9134-42.
PMID: 9371570
PMC: 230214.
DOI: 10.1128/JVI.71.12.9134-9142.1997.
Regulation of EBNA gene transcription in lymphoblastoid cell lines: characterization of sequences downstream of BCR2 (Cp).
Puglielli M, Desai N, Speck S
J Virol. 1997; 71(1):120-8.
PMID: 8985330
PMC: 191031.
DOI: 10.1128/JVI.71.1.120-128.1997.
Response to cAMP levels of the Epstein-Barr virus EBNA2-inducible LMP1 oncogene and EBNA2 inhibition of a PP1-like activity.
Fahraeus R, Palmqvist L, Nerdstedt A, Farzad S, Rymo L, Lain S
EMBO J. 1994; 13(24):6041-51.
PMID: 7813442
PMC: 395581.
DOI: 10.1002/j.1460-2075.1994.tb06950.x.
Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element.
Fahraeus R, Jansson A, Ricksten A, Sjoblom A, Rymo L
Proc Natl Acad Sci U S A. 1990; 87(19):7390-4.
PMID: 2170976
PMC: 54752.
DOI: 10.1073/pnas.87.19.7390.
Role for the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection.
Woisetschlaeger M, Jin X, Yandava C, Furmanski L, Strominger J, Speck S
Proc Natl Acad Sci U S A. 1991; 88(9):3942-6.
PMID: 1850841
PMC: 51569.
DOI: 10.1073/pnas.88.9.3942.
EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus.
Sung N, Kenney S, Gutsch D, Pagano J
J Virol. 1991; 65(5):2164-9.
PMID: 1850003
PMC: 240563.
DOI: 10.1128/JVI.65.5.2164-2169.1991.
Variable expression of latent membrane protein in nasopharyngeal carcinoma can be related to methylation status of the Epstein-Barr virus BNLF-1 5'-flanking region.
Hu L, Minarovits J, Cao S, Rymo L, Falk K, Klein G
J Virol. 1991; 65(3):1558-67.
PMID: 1847471
PMC: 239938.
DOI: 10.1128/JVI.65.3.1558-1567.1991.
Novel downstream elements upregulate transcription initiated from an Epstein-Barr virus latent promoter.
Walls D, Perricaudet M
EMBO J. 1991; 10(1):143-51.
PMID: 1846596
PMC: 452622.
DOI: 10.1002/j.1460-2075.1991.tb07930.x.